Karolinska led team of researchers identifies a new general concept for the treatment of cancer
A team of researchers from five Swedish universities, led by Karolinska Institutet and the Science for Life Laboratory, have identified a new way of treating cancer. The concept is presented in the journal Nature and is based on inhibiting a specific enzyme called MTH1, which cancer cells, unlike normal cells, require for survival. Without this enzyme, oxidized nucleotides are incorporated into DNA, resulting in lethal DNA double-strand breaks in cancer cells.
Bioprinting new organs at Chalmers
With the new 3D Bioprinter, the research group of Professor Paul Gatenholm at the Department of Chemical and Biological Engineering exploits new possibilities of tissue engineering and organ regeneration.
A high-level meeting, on the means for facilitating the transition from scientific discovery to clinical applications in oncology.
25 April 2014
Research Commercialisation is a new cross-discipline event and will provide a platform for all those involved in promoting university-industry-investor collaboration, technology...
19 May 2014
The Academic Enterprise Awards (ACES) Selection Committee meets to short list the finalists of the 2014 awards.
23 June 2014
This new study shows ICT investments could cut healthcare costs for key ailments by more than 35%.
A two-year political fight formally began in Brussels on 30 November with the publication of the European Commission's plan for Horizon 2020, its omnibus R&D programme. It promises less red tape, broader benefits, and more jobs and economic growth.
Key ideas and recommendations to accelerate the deployment of sustainable biofuels have emerged at the second in a series of three high-level academic policy debates on the energy R&D challenge, The Energy Difference